Zhaoze Guo

690 total citations
28 papers, 497 citations indexed

About

Zhaoze Guo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhaoze Guo has authored 28 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Zhaoze Guo's work include Cancer-related molecular mechanisms research (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Zhaoze Guo is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Zhaoze Guo collaborates with scholars based in China, United States and Hong Kong. Zhaoze Guo's co-authors include Guozhu Xie, Changsheng Ye, Minfeng Liu, Jianyu Dong, Jingyun Guo, Min Liang, Lanfang Zhang, Jie Lin, Yawei Yuan and Weihong Guo and has published in prestigious journals such as Scientific Reports, Small and British Journal of Cancer.

In The Last Decade

Zhaoze Guo

26 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaoze Guo China 12 223 148 136 127 83 28 497
Danfeng Luo China 17 328 1.5× 160 1.1× 159 1.2× 95 0.7× 106 1.3× 31 659
Marjan Taherian Iran 5 217 1.0× 141 1.0× 129 0.9× 201 1.6× 83 1.0× 10 525
Zhiyan Zhu China 10 328 1.5× 196 1.3× 122 0.9× 174 1.4× 123 1.5× 11 592
Chun-Ying Qu China 14 271 1.2× 104 0.7× 83 0.6× 152 1.2× 63 0.8× 25 563
Kun Ke China 16 251 1.1× 161 1.1× 100 0.7× 140 1.1× 76 0.9× 39 586
Yamin Zhang China 13 344 1.5× 139 0.9× 79 0.6× 139 1.1× 98 1.2× 26 561
Enqi Qiao China 14 203 0.9× 93 0.6× 99 0.7× 146 1.1× 40 0.5× 25 475
Bai Ji China 12 273 1.2× 160 1.1× 215 1.6× 111 0.9× 93 1.1× 36 618

Countries citing papers authored by Zhaoze Guo

Since Specialization
Citations

This map shows the geographic impact of Zhaoze Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoze Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoze Guo more than expected).

Fields of papers citing papers by Zhaoze Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoze Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoze Guo. The network helps show where Zhaoze Guo may publish in the future.

Co-authorship network of co-authors of Zhaoze Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoze Guo. A scholar is included among the top collaborators of Zhaoze Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoze Guo. Zhaoze Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Huimin, et al.. (2025). The role of MMPs in intracerebral hemorrhage. Frontiers in Cell and Developmental Biology. 13. 1667228–1667228.
3.
Zhu, Nan, Qiuping Yang, Haolin Chen, et al.. (2024). Self‐Oxygenated Hydrogel Enhances Immune Cell Response and Infiltration Via Triggering Dual DNA Damage to Activate cGAS‐STING and Inhibiting CAFs. Small. 20(45). e2403428–e2403428. 9 indexed citations
4.
Lin, Xiaotong, Xin Dong, Kunyuan Wang, et al.. (2024). Radiotherapy enhances the anti-tumor effect of CAR-NK cells for hepatocellular carcinoma. Journal of Translational Medicine. 22(1). 929–929. 16 indexed citations
5.
Guo, Zhaoze, Han Zhang, Yiming Fu, et al.. (2023). Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6. Cell Death Discovery. 9(1). 6–6. 69 indexed citations
6.
Feng, Xiaoli, Tian Lin, Dong Chen, et al.. (2023). Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2α pathway under PTT/CDT combined therapy. Acta Biomaterialia. 160. 211–224. 76 indexed citations
7.
Zhang, Han, Jieling Zheng, Yiming Fu, et al.. (2023). Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation. Breast Cancer Research and Treatment. 198(3). 437–446. 10 indexed citations
8.
Yang, Jia, Nan Zhu, Ying Chen, et al.. (2023). Tumor-targeting hydroxyapatite nanoparticles for remodeling tumor immune microenvironment (TIME) by activating mitoDNA-pyroptosis pathway in cancer. Journal of Nanobiotechnology. 21(1). 470–470. 22 indexed citations
9.
Jiang, Shanshan, Si‐Min Ruan, Lijun Zhu, et al.. (2022). Cardiovascular risk factors and breast cancer incidence in a large middle-aged cohort study. BMC Cancer. 22(1). 534–534. 7 indexed citations
10.
Wang, Baiyao, Wei Liu, Chunshan Liu, et al.. (2022). Cancer-Associated Fibroblasts Promote Radioresistance of Breast Cancer Cells via the HGF/c-Met Signaling Pathway. International Journal of Radiation Oncology*Biology*Physics. 116(3). 640–654. 33 indexed citations
12.
Wang, Baiyao, Xiaoting Huang, Hongli Yang, et al.. (2021). PLK1 Inhibition Sensitizes Breast Cancer Cells to Radiation via Suppressing Autophagy. International Journal of Radiation Oncology*Biology*Physics. 110(4). 1234–1247. 42 indexed citations
13.
Jiang, Shanshan, Si‐Min Ruan, Zhaoze Guo, et al.. (2021). MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cells. Molecular Medicine Reports. 24(2). 9 indexed citations
14.
Liu, Minfeng, Zhaoze Guo, Jiang-Qin Liu, et al.. (2021). Preparing PAMAM-NK4 nano complexes and examining their in vitro growth suppression effects in breast cancer. Gland Surgery. 10(9). 2695–2704. 2 indexed citations
15.
Bai, Xue, et al.. (2021). OA07.07 PARP1 Inhibitors Enhanced IFNγ-Induced PD-L1 Expression in LKB1-Mutant Lung Cancer. Journal of Thoracic Oncology. 16(3). S117–S118. 2 indexed citations
16.
Guo, Zhaoze, et al.. (2021). Methylated biomarkers for breast cancer identified through public database analysis and plasma target capture sequencing. Annals of Translational Medicine. 9(8). 683–683. 5 indexed citations
17.
Guo, Jingyun, Can Luo, Jianyu Dong, et al.. (2021). MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway. Cancer Management and Research. Volume 13. 403–413. 21 indexed citations
18.
Xie, Guozhu, Ying Liu, Qiwei Yao, et al.. (2017). Hypoxia-induced angiotensin II by the lactate-chymase-dependent mechanism mediates radioresistance of hypoxic tumor cells. Scientific Reports. 7(1). 42396–42396. 30 indexed citations
19.
Xie, Guozhu, Aimin Ji, Quan Yuan, et al.. (2014). Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines. British Journal of Cancer. 110(10). 2514–2523. 34 indexed citations
20.
Huang, Weibin, et al.. (2011). [Value of cardiac troponin I measurement in prediction of anthracycline-induced cardiotoxicity in breast cancer patients].. PubMed. 31(6). 1047–50. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026